- €505.74m
- €589.89m
- €225.62m
Brief: Lumibird Confirms 2023 Objectives
Brief: Lumibird H1 Revenue Up At EUR 84.0 Million
Brief: Lumibird Medical Creates Subsidiary In India
Brief: Saab To Divest Laser Rangefinder Business
Brief: Lumibird Completes Acquisition of Saab's Defense Laser Rangefinder Business
Brief: Lumibird Q1 Revenue Up 12% At EUR 38 Million
Brief: Lumibird FY EBITDA Up At EUR 32.6 Million
Brief: Lumibird FY Consolidated Revenue Up At 162.5 Million Euros
Brief: Lumibird 9-Month Revenue Up At 112.6 Million Euros
Brief: Lumibird H1 EBITDA Up 88% At 14.3 Millions Euros
Brief: Lumibird H1 Revenue Up 13% At 75.5 Million Euros
Brief: Lumibird Completes Purchase Of Areva's 37% Stake In Cilas
Brief: Lumibird Says It Is In Exclusive Bid To Buy Areva's Stake In Cilas
Brief: Lumibird Q1 Revenues Rise To 33.8 million euros
Brief: Lumibird Q1 Consolidated Revenues At 33.8 Million Euros, Up 66%
Brief: Lumibird Medical's Glaucoma Treatment Potential Strengthened By EGS Recommendations
Brief: Lumibird FY Current Operating Income Up At EUR 14.1 Mln
Brief: Lumibird Announces Signed Agreement To Acquire Saab Group’s Defense Laser Rangefinder Business
Brief: Lumibird FY Revenue Up 14.4% At 126.7 Million Euros